Okuda & Marshall-Warren Lectures

Okuda State-of-the-Art Lecture

Professor Kunio Okuda was one of the pioneers of hepatology and a great supporter of gastroenterology and the study of liver disease in the Asia Pacific region. In the course of a career that flourished for more than 50 years since publishing his first paper he made an extraordinary number of contributions to the field. He published many books and innumerable articles and reviews. He also trained and influenced two generations of liver specialists from throughout the Asia Pacific region as well as from his native Japan.

Among his accomplishments - which included receiving many Japanese and international distinctions, prizes and awards - he was perhaps most proud of having been a co-founder of the Asian Pacific Association for the Study of the Liver (APASL). He was also an inaugural Editor of the Journal of Gastroenterology (Editor-in-Chief until the time of his death in February 2003) and a founding Trustee of the JGH Foundation. With his permission the JGH State-of-the-Art Lecture was renamed the Okuda Lecture in September 2002.

First Okuda Lecture

The first Okuda Lecture was delivered at the APASL meeting in Taipei in 2002, in the presence of Professor Okuda, by Professor Geoffrey Farrell from Sydney, Australia and was titled ‘NASH. What is it and why is it important in the Asia Pacific Region’

 

Marshall & Warren Luminal Gastroenterology Lecture

In 2007 the JGH Foundation introduced a distinguished lecture in the area of luminal gastroenterology. The lecture was to be delivered each year during Asia Pacific Digestive Week. From 2008 onwards this lecture is to be known as the Marshall & Warren Lecture to recognise the pivotal contribution to luminal gastroenterology made by Professor Barry Marshall and Professor Robin Warren, both from Western Australia.  Professors Marshall and Warren received the Nobel Prize in Medicine in 2005 for their discovery of the principal causal agent of peptic ulcer disease and of a major aetiological factor in gastric cancer - the bacterium Helicobacter Pylori. Their discovery has changed the landscape for the management of peptic ulcer disease throughout the world.